Cart
sales@molnova.com
N.41
CAS No. 357441-99-7
N.41( HIV inhibitor N.41 | Vif inhibitor N.41 )
Catalog No. M14228 CAS No. 357441-99-7
N.41 (HIV inhibitor N.41, Vif inhibitor N.41) is a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G (A3G) protein (IC50=2.2 uM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 50MG | 1782 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameN.41
-
NoteResearch use only, not for human use.
-
Brief DescriptionN.41 (HIV inhibitor N.41, Vif inhibitor N.41) is a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G (A3G) protein (IC50=2.2 uM).
-
DescriptionN.41 (HIV inhibitor N.41, Vif inhibitor N.41) is a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G (A3G) protein (IC50=2.2 uM); shows potent antiviral activity in A3G(+) but not in A3G(-) T cells with IC50 of 8.4 uM and TC50 of >100 uM against HIV-1Ba-L replication in peripheral blood mononuclear cells; inhibits the Vif-A3G interaction and increases cellular A3G levels and incorporation of A3G into virions, thereby attenuating virus infectivity in a Vif-dependent manner.
-
In Vitro——
-
In Vivo——
-
SynonymsHIV inhibitor N.41 | Vif inhibitor N.41
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number357441-99-7
-
Formula Weight254.289
-
Molecular FormulaC15H14N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC/C(NC1=CC=C(O)C=C1)=C/C(C2=CC=CN=C2)=O
-
Chemical Name3-((4-hydroxyphenyl)amino)-1-(pyridin-3-yl)but-2-en-1-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Pery E, et al. J Biol Chem. 2015 Apr 17;290(16):10504-17.
molnova catalog
related products
-
ABX464
ABX464 (ABX-464, ABX 464) is a novel class of anti-HIV small molecule targeting Rev-mediated viral RNA biogenesis.
-
14-Dicaffeoylquinic ...
14-Dicaffeoylquinic acid has antioxidant activity.14-Dicaffeoylquinic acid is a potent and highly selective class of HIV-1 integrase inhibitors inhibitsHIV-1 replication in MT-2 cell culture at non-toxic concentrations.
-
HIV-1 inhibitor 18A
HIV-1 inhibitor 18A is a novel broad HIV-1 inhibitor that blocks envelope glycoprotein transitions critical for entry.
